Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07312903 · ClinicalTrials.gov registry record · Phase 1

DPTX3186 in Wnt Pathway Activated Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Dewpoint Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
40
Enrollment target
2
Study locations

NCT07312903 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by Dewpoint Therapeutics. The registered enrollment target is 40 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07312903, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by Dewpoint Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This is a first-in human clinical study of DPTX3186 in subjects with Wnt-pathway activated solid tumors where no other treatments exist. The study will evaluate safety, pharmacokinetics, and initial activity of DPTX3186, as well as explore pharmacodynamic parameters to identify potential biomarkers of efficacy

Conditions Studied

Solid Tumors

Interventions

  • DRUG DPTX3186

Study Locations (2)

Texas

  • NEXT San Antonio - San Antonio

Virginia

  • NEXT Virginia - Fairfax

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-01
Est. Completion 2028-06-30
Phase Phase 1

Sponsor

Dewpoint Therapeutics

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07312903

The ClinicalTrials.gov registry entry for NCT07312903 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (86% lower). The listed sponsor is Dewpoint Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which DPTX3186 is the first listed.

NCT07312903 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Virginia.

Frequently Asked Questions

What is clinical trial NCT07312903 about?

NCT07312903 is a clinical study titled "DPTX3186 in Wnt Pathway Activated Solid Tumors". This is a first-in human clinical study of DPTX3186 in subjects with Wnt-pathway activated solid tumors where no other treatments exist. The study will evaluate safety, pharmacokinetics, and initial activity of DPTX3186, as well as explore pharmacodynamic parameters to identify potential biomarkers ...

What is the current status of trial NCT07312903?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2026-01. Estimated completion is 2028-06-30.

What conditions does trial NCT07312903 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT07312903?

The interventions under investigation include: DPTX3186 (DRUG).

Who is sponsoring clinical trial NCT07312903?

This trial is sponsored by Dewpoint Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07312903 being conducted?

This trial has 2 study locations across Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.